Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Wu

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Journal of Cellular Physiology|June 23, 2010
Origin of cardiac progenitor cells in the developing and postnatal heartElizabeth N Kuhn, Sean M Wu
Current Cardiology Reports|March 19, 2017
Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease ModelsJan W Buikema, Sean M Wu
Current Treatment Options in Cardiovascular Medicine|September 2, 2015
Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative MedicineArun Sharma, Yuan Zhang, Sean M Wu
Drug Discovery Today. Disease Mechanisms|December 25, 2010
Promises and pitfalls in cell replacement therapy for heart failureMarkus Krane, Oliver Wernet, Sean M Wu
Stem Cell Research & Therapy|January 31, 2014
Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningArun Sharma, Joseph C Wu, Sean M Wu
The Journal of Clinical Investigation|June 27, 2017
The relationship between cardiac endothelium and fibroblasts: it's complicatedRavi Karra, Agoston O Walter, Sean M Wu
Current Protocols in Molecular Biology|January 13, 2012
Reprogramming of mouse, rat, pig, and human fibroblasts into iPS cellsKuppusamy Rajarajan, Marc C Engels, Sean M Wu
Drug Discovery Today. Disease Models|May 22, 2013
Induced pluripotent stem cell modeling of complex genetic diseasesJ Travis Hinson, Kenta Nakamura, Sean M Wu
Med (New York, N.Y.)|January 14, 2023
The potential of auto-antigen-guided treatment of immune checkpoint inhibitor-mediated myocarditisHan Zhu, Yuhsin Vivian Huang, Sean M Wu
Nature Cardiovascular Research|August 28, 2024
Cardiac ACTN2 enhancer regulates cardiometabolism and maturationFrancisco X Galdos, Carissa Lee, Sean M Wu
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Journal of Cellular Physiology|June 23, 2010
Origin of cardiac progenitor cells in the developing and postnatal heartElizabeth N Kuhn, Sean M Wu
Current Cardiology Reports|March 19, 2017
Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease ModelsJan W Buikema, Sean M Wu
Current Treatment Options in Cardiovascular Medicine|September 2, 2015
Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative MedicineArun Sharma, Yuan Zhang, Sean M Wu
Drug Discovery Today. Disease Mechanisms|December 25, 2010
Promises and pitfalls in cell replacement therapy for heart failureMarkus Krane, Oliver Wernet, Sean M Wu
Stem Cell Research & Therapy|January 31, 2014
Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningArun Sharma, Joseph C Wu, Sean M Wu
The Journal of Clinical Investigation|June 27, 2017
The relationship between cardiac endothelium and fibroblasts: it's complicatedRavi Karra, Agoston O Walter, Sean M Wu
Current Protocols in Molecular Biology|January 13, 2012
Reprogramming of mouse, rat, pig, and human fibroblasts into iPS cellsKuppusamy Rajarajan, Marc C Engels, Sean M Wu
Drug Discovery Today. Disease Models|May 22, 2013
Induced pluripotent stem cell modeling of complex genetic diseasesJ Travis Hinson, Kenta Nakamura, Sean M Wu
Med (New York, N.Y.)|January 14, 2023
The potential of auto-antigen-guided treatment of immune checkpoint inhibitor-mediated myocarditisHan Zhu, Yuhsin Vivian Huang, Sean M Wu
Nature Cardiovascular Research|August 28, 2024
Cardiac ACTN2 enhancer regulates cardiometabolism and maturationFrancisco X Galdos, Carissa Lee, Sean M Wu
Pageof 14